Clinically suspected anaphylaxis induced by sugammadex in a patient with Weaver syndrome undergoing restrictive mammoplasty surgery A case report with the literature review

被引:10
作者
Bedirli, Nurdan [1 ]
Isik, Berrin [1 ]
Bashiri, Mehrnoosh [1 ]
Pampal, Kutluk [1 ]
Kurtipek, Omer [1 ]
机构
[1] Gazi Univ, Med Fac, Anesthesiol Dept, Ankara, Turkey
关键词
anaphylaxis; arrhythmia; hypotension; sugammadex; NEUROMUSCULAR BLOCKING-AGENTS; REVERSAL;
D O I
10.1097/MD.0000000000009661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Sugammadex is a cylodextrin derivate that encapsulates steroidal neuromuscular blocker agents and is reported as a safe and well-tolerated drug. In this case report, we present a patient who developed grade 3 anaphylaxis just after sugammadex administration. Patient concerns: A 22-year-old woman with diagnosis of Weaver syndrome was scheduled for bilateral mammoplasty and resection of unilateral accessory breast tissue resection. Anesthesia was induced and maintained by propofol, rocuronium, and remifentanil. At the end of the operation, sugammadex was administered and resulted in initially hypotension and bradycardia then the situation worsened by premature ventricular contraction and bigeminy with tachycardia, bronchospasm, and hypoxia. Diagnosis: The Ring and Messmer clinical severity scale grade 3 anaphylactic reaction occurred just after sugammadex injection and the patient developed prolonged hypotension with recurrent cardiac arrhythmias in postoperative 12 hours. Interventions: Treatment was initiated bolus injections of ephedrine, epinephrine, lidocaine, steroids and antihistaminic and continued with lidocaine bolus dosages and norepinephrine infusion for the postoperative period. Outcomes: The general condition of the patient improved to normal 3 hours after the sugammadex injection, and she was moved to the intensive care unit. At 2nd and 8th hours of intensive care unit follow-up, she developed premature ventricular contraction and bigeminy with the heart rate of 130 to 135 beats/min, which returned to sinus rhythm with 50 mg lidocaine. After that, no symptoms were observed and the patient was discharged to plastic surgery clinic at the following day. Lessons: Sugammadex may result in life-treating anaphylactic reaction even in a patient who did not previously expose to drug. Moreover, prolonged cardiovascular collapse and cardiac arrhythmias may occur.
引用
收藏
页数:4
相关论文
共 16 条
[1]   Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge [J].
Butterly, A. ;
Bittner, E. A. ;
George, E. ;
Sandberg, W. S. ;
Eikermann, M. ;
Schmidt, U. .
BRITISH JOURNAL OF ANAESTHESIA, 2010, 105 (03) :304-309
[2]   Bleeding Risk in Surgical Patients Receiving Sugammadex: Definitive Conclusions Are Not Yet Possible [J].
Carron, Michele .
ANESTHESIOLOGY, 2015, 123 (05) :1212-1212
[3]   Three cases of suspected sugammadex-induced hypersensitivity reactions [J].
Godai, K. ;
Hasegawa-Moriyama, M. ;
Kuniyoshi, T. ;
Kakoi, T. ;
Ikoma, K. ;
Isowaki, S. ;
Matsunaga, A. ;
Kanmura, Y. .
BRITISH JOURNAL OF ANAESTHESIA, 2012, 109 (02) :216-218
[4]   Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study [J].
Grosse-Sundrup, Martina ;
Henneman, Justin P. ;
Sandberg, Warren S. ;
Bateman, Brian T. ;
Uribe, Jose Villa ;
Nicole Thuy Nguyen ;
Ehrenfeld, Jesse M. ;
Martinez, Elizabeth A. ;
Kurth, Tobias ;
Eikermann, Matthias .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
[5]   Postoperative residual block after intermediate-acting neuromuscular blocking drugs [J].
Hayes, AH ;
Mirakhur, RK ;
Breslin, DS ;
Reid, JE ;
McCourt, KC .
ANAESTHESIA, 2001, 56 (04) :312-318
[6]   Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report [J].
Kawano, Takashi ;
Tamura, Takahiko ;
Hamaguchi, Mayuko ;
Yatabe, Tomoaki ;
Yamashita, Koichi ;
Yokoyama, Masataka .
JOURNAL OF CLINICAL ANESTHESIA, 2012, 24 (01) :62-64
[7]  
Meyer M.J., 2013, BMJ, V346, pf1460, DOI DOI 10.1136/BMJ.F1460
[8]  
Miyazaki Y, 2017, ANESTH ANALG, V19, P1
[9]   Sugammadex: Another milestone in clinical neuromuscular pharmacology [J].
Naguib, Mohamed .
ANESTHESIA AND ANALGESIA, 2007, 104 (03) :575-581
[10]  
RING J, 1977, LANCET, V1, P466